Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Skin problems can indicate different diseases inside the body.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Platelet lysate could be a valuable treatment for many diseases in regenerative medicine.

Mesenchymal stem cells are effective and safe for treating various diseases in children.

CMV infection increases the risk of GvHD after bone marrow transplants.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.